Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 439-443

  Verkaik, Nicole S ^a,b   Trapman, Jan ^a   Romijn, Johannes C ^a   Van Der Kwast, Theodorus H ^a   Van Steenbrugge, Gert J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DNA; HERMES ANTIGEN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ANTIGENS, CD44; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032932869     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<439::AID-IJC17>3.0.CO;2-V     Document Type: Article

References (25)

1. BOOKSTEIN, R., BOVA, G.S., MACGROGAN, D., LEVY, A. and ISAACS, W.B., Tumour-suppressor genes in prostatic ontogenesis: a positional approach. Brit. J. Urol., 79, 28-36 (1997).
2. BRACKE, M.E., VYNCKE, B.M., BRUYNEEL, E.A., VERMEULEN, S.J., DE BRUYNE, G.K., VAN LAREBEKE, N.A., VLEMINCKX, K., VAN ROY, F.M. and MAREEL, M.M., Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Brit. J. Cancer, 68, 282-289 (1993).
3. DALL, P., HEIDER, K.-H., HEKELE, A., VON MINCKWITZ, G., KAUFMANN, M., PONTA, H. and HERRLICH, P., Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res., 54, 3337-3341 (1994).
4. GAO, A.C., LOU, W., DONG, J.-T. and ISAACS, J.T., CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res., 57, 846-849 (1997).
5. GARDINER-GARDEN, M. and FROMMER, M., CpG islands in vertebrate genomes. J. mol. Biol., 196, 261-282 (1987).
6. GONZALGO, M.L. and JONES, P.A., Mutagenic and epigenetic effects of DNA methylation. Mutation Res., 386, 107-118 (1997).
7. GRAFF, J.R., HERMAN, J.G., LAPIDUS, R.G., CHOPRA, H., XU, R., JARRARD, D.F., ISAACS, W.B., PITHA, P.M., DAVIDSON, N.E. and BAYLIN, S.B., E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinoma. Cancer Res., 55, 5195-5199 (1995).
8. JOHANSSON, J.-E., HOLMBERG, L., JOHANSSON, S., BERGSTRÖM, R. and ADAMI, H.-O., A prospective, population-based study in Sweden. J. Amer. med. Ass., 277, 467-471 (1997).
9. KALLAKURY, B.V.S., YANG, F. FIGGE, J., SMITH, K.E., KAUSIK, S.J., TACY, N.J., FISHER, H.A.G., KAUFMAN, R., FIGGE, H. and ROSS, J.S., Decreased levels of CD44 protein and mRNA in prostate carcinoma. Cancer, 78, 1461-1469 (1996).
10. KAUTIAINEN, T.L. and JONES, P.A., DNA methyltransferase levels in tumorigenic and non-tumorigenic cells in culture. J. biol. Chem., 261, 1594-1598 (1986).
11. KOGERMAN, P., SY, M.-S. and CULP, L.A., Counter-selection for overexpressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. Oncogene, 15, 1407-1416 (1997).
12. LEE, W.H., ISAACS, W.B., BOVA, G.S. and NELSON, W.G., CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol. Biomarkers Prev., 6, 443-450 (1997).
13. MOSTOSLAVSKY, R. and BERGMAN, Y., DNA methylation: regulation of gene expression and role in immune system. Biochim. biophys. Acta, 1333, F29-50 (1997).
14. NAOR, D., SIONOV, R.V. and ISH-SHALOM, D., CD44: structure, function, and association with the malignant process. Adv. Cancer Res., 71, 241-319 (1997).
15. NELSON, J.B., LEE, W.-H., NGUYEN, S.H., JARRARD, D.F., BROOKS, J.D., MAGNUSON, S.R., OPGENORTH, T.J., NELSON, W.G. and BOVA, G.S., Methylation of the 5′ CpG island of the endothelin B receptor is common in human prostate cancer. Cancer Res., 57, 35-37 (1997).
16. NOORDZIJ, M.A., VAN STEENBRUGGE, G.-J., VERKAIK, N.S., SCHRÖDER, F.H. and VAN DER KWAST, T.H., The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin. Cancer Res., 3, 805-815 (1997).
17. PARKER, S.L., TONG, T., BOLDEN, S. and WINGO, P.A., Cancer statistics, 1997. CA Cancer J. Clin., 47, 25-27 (1997).
18. ROMIJN, J.C., ERKENS-SCHULZE, S. and SCHRÖDER, F.H., Perspectives of the use of tissue culture methods as an alternative to human prostate-cancer xenografts in nude mice. In: H. Huber and W. Queißer (eds.), Contributions to oncology, Vol. 51: immunodeficient animals: models for cancer research, pp. 209-213, Karger, Basel (1996).
19. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Isolation of DNA from mammalian cells: protocol I. In: C. Nolan (ed.), Molecular cloning: a laboratory manual, 2nd ed., Vol. 2, pp. 9.16-19, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
20. SHIMAZUI, T., GIROLDI, L.A., BRINGUIER, P.P., OOSTERWIJK, E. and SCHALKEN, J.A., Complex cadherin expression in renal cell carcinoma. Cancer Res., 56, 3234-3237 (1996).
21. SHTIVELMAN, E. and BISHOP, M., Expression of CD44 is repressed in neuroblastoma cells. Mol. cell. Biol., 11, 5446-5453 (1991).
22. STEVENS, J.W., PALECHEK, P.L., GRIEBLING, T.L., MIDURA, R.J., ROKHLIN, O.W. and COHEN, M.B., Expression of CD44 isoforms in human prostate tumor cell lines. Prostate, 28, 153-161 (1996).
23. SY, M.S., MORI, H. and LIU, D., CD44 as a marker in human cancers. Curr. Opin. Oncol., 9, 108-112 (1997).
24. VAN ROY, F., VLEMINCKX, K., VAKAET, L., BERX, G., FIERS, W. and MAREEL, M., The invasion suppressor role of E-cadherin. In: H. Rabes, P.E. Peters and K. Munk (eds.), Metastasis: basic research and its clinical applications (44), Contributions to Oncology, pp. 108-126, Karger, Basel (1992).
25. ZINGG, J.-M. and JONES, P.A., Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis, 18, 869-882 (1997).